Decoding the Tumor Immune Landscape: Emerging TIL Subsets As Prognostic Biomarkers and Therapeutic Targets

Scientists investigate functions of tumor -infiltrating lymphocytes populations beyond the traditional markers like CD3 and CD8 across different cancers while concentrating on predictive outcomes in immunotherapy.